O-16 - Current Issues in Public Health

Co-Author(s)

• NA

  Nisha Alden, MPH

  Respiratory and Invasive Bacterial Disease Program Manager
  Communicable Disease Branch
  Colorado Department of Public Health and Environment
  Denver, Colorado

  Disclosure: CDC: Grant/Research Support
• MA

  Mirasol Apostol, MPH

  Project Coordinator
  California Emerging Infections Program
  Oakland, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• BB

  Bernard Beall, PhD

  Director, Streptococcus Laboratory
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SC

  Sopio Chochua, M.D., Ph.D.

  Microbiologist
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JC

  Janet Cragan, MD

  Medical Officer
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AD

  Augustina Delaney, PhD, CNM

  Clinician
  Eagle Global Services
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MF

  Monica Farley, MD

  Professor
  Infectious Diseases
  Emory University
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DG

  Diana Garbinsky, MS

  Statistician
  RTI Health Solutions
  Research Triangle Park, North Carolina

  Disclosure: GSK (Other Financial or Material Support, The study was conducted by RTI Health Solutions, which received consultancy fees from GSK. I am a salaried employee at RTI Health Solutions and received no direct compensation from GSK for the conduct of this study..)
• SG

  Suzanne Gilboa, PhD, MHS

  Senior Scientist
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LH

  Lee Harrison, MD

  Head, Infectious Diseases Epidemiology Research Unit
  University of Pittsburgh
  Pittsburgh, Pennsylvania

  Disclosure: Dynavax (Consultant)GSK (Consultant)Merck (Consultant)OMVax (Consultant)Pfizer (Consultant)Sanofi Pasteur (Consultant)
• CH

  Cosmina Hogea, PhD

  Director
  US Health Outcomes and Epidemiology
  GSK
  Philadelphia, Pennsylvania

  Disclosure: GlaxoSmithKline (Employee, Shareholder)
• CH

  Corinne Holtzman, MPH

  Epidemiologist Senior
  Minnesota Department of Health
  St. Paul, Minnesota

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MH

  Margaret Honein, PhD, MPH

  Division Director/Senior Epidemiologist
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DH

  David Hong, MD

  Director, Clinical Research
  Vir Biotechnology
  San Francisco, California

  Disclosure: Vir Biotechnology : Employee
• SH

  Shannon Hunter, MS

  Director, Biostatistics
  RTI Health Solutions
  Research Triangle Park, North Carolina

  Disclosure: GSK (Other Financial or Material Support, Ms. Hunter is an employee of RTI Health Solutions, who received consultancy fees from GSK for conduct of the study. Ms. Hunter received no direct compensation from the Sponsor.)
• 

  Elizabeth La, PhD

  Associate Director, Health Economics
  RTI Health Solutions
  Research Triangle Park, North Carolina

  Disclosure: RTI Health Solutions (Employee)
• LM

  Lesley McGee, Ph.D

  Microbiologist
  Respiratory Diseases Branch
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CM

  Cynthia Moore, MD, PhD

  Chief Medical Officer, NCBDDD
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JM

  Jazmyn Moore, MPH

  Health Scientist
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AN

  Aimee Near, MPH

  Principal
  Medical and Scientific Services
  IQVIA
  Durham, North Carolina

  Disclosure: Employee of IQVIA; IQVIA paid by VIR Bio to complete research project (Consultant)
• JP

  J. Zachary Porterfield, MD, PhD

  Assistant Professor
  Internal Medicine, Division of Infectious Disease
  University of Kentucky College of Medicine
  Lexington, Kentucky

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• CR

  Charles E. Rose, PhD

  Biostatistician
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NR

  Nicole Roth, MPH

  Epidemiologist
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KS

  Kathryn Sabitus, MS

  Research Program Manager
  Infectious Diseases
  University of Kentucky HealthCare
  Lexington, Kentucky

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SS

  Stephanie Schrag, DPhil

  Epidemiologist
  CDC
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JS

  J. Erin Staples, MD, PhD

  Medical Officer
  U.S. CDC
  Ft. Collins, Colorado

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• TS

  Tiffany Stivers, MSN, APRN

  Advanced Practice Provider
  Infectious Diseases
  University of Kentucky
  Lexington, Kentucky

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AT

  Ann Thomas, MD, MPH

  Public Health Physician
  Oregon Public Health Division
  Portland, Oregon

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AT

  Alice Thornton, MD

  Professor
  Infectious Diseases
  University of Kentucky
  Lexington, Kentucky

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• VT

  Van Tong, MPH

  Lead Epidemiologist
  U.S. CDC
  Chamblee, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• ST

  Salina Torres, PhD, MPH

  Active Bacterial Core Surveillance Project Coordinator
  New Mexico Department of Health
  Santa Fe, New Mexico

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JT

  Jenny Tse, MS

  Associate Consultant
  IQVIA
  Cambridge, Massachusetts

  Disclosure: Vir Biotechnology, Inc. (Other Financial or Material Support, I am employed by IQVIA which was paid by Vir Biotechnology, Inc. to complete this study.)
• MV

  Miguel Valencia-Prado, MD

  Director
  Children with Special Health Care Needs
  Puerto Rico Department of Health
  San Juan, Puerto Rico

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RW

  Ryan Weeks, BS

  Project Data Manager
  Infectious Diseases
  University of Kentucky HealthCare
  Lexington, Kentucky

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• YY

  Yinong Young-Xu, ScD

  Director
  Clinical Epidemiology
  VA Medical Center
  White River Junction, Vermont

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Sarah Blevins, PharmD

  HIV Clinical Pharmacist
  University of Kentucky HealthCare
  Lexington, Kentucky

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Miwako Kobayashi, MD, MPH

  Medical Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Sara Poston, PharmD

  Head, US Health Outcomes Research, Vaccines
  GSK
  Lancaster, Pennsylvania

  Disclosure: The GlaxoSmithKline group of companies (Employee, Shareholder)

  Slides Slides and Audio
• 

  Carolina Reyes, PhD

  Senior Director Health Economics & Market Access
  Vir Biotechnology
  San Francisco, CA

  Disclosure: Vir Biotechnology (Employee, Shareholder)

  Slides Slides and Audio
• 

  Laura Zambrano, PhD, MPH

  Epidemiologist
  U.S. Centers for Disease Control and Prevention
  Chamblee, GA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• A Descriptive Analysis of a Multi-disciplinary Approach to Opioid Use Disorder Treatment Within an Infectious Diseases Clinic
  Sarah R. Blevins, PharmD – University of Kentucky HealthCare; Tiffany Stivers, MSN, APRN – University of Kentucky; Kathryn Sabitus, MS – University of Kentucky HealthCare; Ryan Weeks, BS – University of Kentucky HealthCare; J. Zachary Porterfield, MD, PhD – University of Kentucky College of Medicine; Alice Thornton, MD – University of Kentucky
• Clarifying the Congenital Zika Syndrome Phenotype and Expanding to Congenital Zika Spectrum in the Absence of Laboratory Evidence
  Laura D. Zambrano, PhD, MPH – U.S. Centers for Disease Control and Prevention; Augustina Delaney, PhD, CNM – Eagle Global Services; Charles E. Rose, PhD – U.S. CDC; Suzanne Gilboa, PhD, MHS – U.S. CDC; Van Tong, MPH – U.S. CDC; Miguel Valencia-Prado, MD – Puerto Rico Department of Health; Nicole Roth, MPH – U.S. CDC; Janet Cragan, MD – U.S. CDC; Jazmyn Moore, MPH – U.S. CDC; J. Erin Staples, MD, PhD – U.S. CDC; Margaret Honein, PhD, MPH – U.S. CDC; Cynthia Moore, MD, PhD – U.S. CDC
• Characterization of Group B streptococcus Strains with Reduced Susceptibility to Beta-lactam Antibiotics, Active Bacterial Core Surveillance, 1998–2017
  Miwako Kobayashi, MD, MPH – Centers for Disease Control and Prevention; Lesley McGee, Ph.D – Centers for Disease Control and Prevention; Sopio Chochua, M.D., Ph.D. – Centers for Disease Control and Prevention; Mirasol Apostol, MPH – California Emerging Infections Program; Nisha B. Alden, MPH – Colorado Department of Public Health and Environment; Monica M. Farley, MD – Emory University; Lee Harrison, MD – University of Pittsburgh; Corinne Holtzman, MPH – Minnesota Department of Health; Salina Torres, PhD, MPH – New Mexico Department of Health; Ann Thomas, MD, MPH – Oregon Public Health Division; Bernard Beall, PhD – Centers for Disease Control and Prevention; Stephanie Schrag, DPhil – CDC
• Health Resource Burden of Influenza Among the Elderly with Underlying Conditions in the United States
  Aimee Near, MPH – IQVIA; Jenny Tse, MS – IQVIA; Yinong Young-Xu, ScD – VA Medical Center; David K. Hong, MD – Vir Biotechnology; Carolina M. Reyes, PhD – Vir Biotechnology
• Impact of State of Residence on Adult Vaccination Uptake: A Multilevel Modeling Approach
  Shannon Hunter, MS – RTI Health Solutions; Diana Garbinsky, MS – RTI Health Solutions; Elizabeth M. La, PhD – RTI Health Solutions; Sara Poston, PharmD – GSK; Cosmina Hogea, PhD – GSK